Department of Rheumatology, National Hospital Organization Ureshino Medical Center, Ureshino, Japan.
Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Front Immunol. 2023 Feb 28;14:1141407. doi: 10.3389/fimmu.2023.1141407. eCollection 2023.
In patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis, prediction of renal survival should guide the choice of therapy, but a prediction of the histological classification has inconsistencies.
To evaluate the usefulness of renal risk score (RRS) for Japanese patients with ANCA-associated glomerulonephritis (AAGN) and compare the prediction for end-stage renal disease (ESRD) between RRS and the histological classification.
We retrospectively analyzed 96 patients with AAGN who underwent a renal biopsy. Renal survival was categorized by RRS, and the histological classification was assessed separately. We compared the predictive values for RRS and the histological classification.
The median observational period was 37.5 (interquartile range [IQR] 21.5-77.0) months. The median RRS point at the time of renal biopsy was 2 (IQR 0-7.8), and the patients were categorized into low- (n = 29), medium- (n = 43), and high-risk groups (n = 24) using RRS. As expected, the renal prognosis was the worst in the "high-risk" group and the best in the "low-risk" group. In the histological classification, the survival deteriorated progressively from "focal" (best) to "mixed," "crescentic," and "sclerotic" (worst) classes, different from the order in the original proposal for this system. Multivariable Cox regression analysis revealed that RRS was independently associated with ESRD. The difference in prediction for renal survival between RRS and the histological classification was not significant using area under receiver-operating-characteristic curves.
We evaluated the usefulness of RRS in Japanese patients with AAGN and found it a stable predictor of renal survival in such patients.
在抗中性粒细胞胞浆抗体(ANCA)相关性肾小球肾炎患者中,预测肾脏存活率应指导治疗选择,但组织学分类的预测存在不一致性。
评估肾风险评分(RRS)在日本 ANCA 相关性肾小球肾炎(AAGN)患者中的应用价值,并比较 RRS 与组织学分类对终末期肾病(ESRD)的预测作用。
我们回顾性分析了 96 例接受肾活检的 AAGN 患者。根据 RRS 对肾脏存活率进行分类,并单独评估组织学分类。我们比较了 RRS 和组织学分类的预测价值。
中位观察期为 37.5(四分位距[IQR] 21.5-77.0)个月。肾活检时 RRS 评分中位数为 2(IQR 0-7.8),患者根据 RRS 分为低危(n=29)、中危(n=43)和高危组(n=24)。正如预期的那样,高危组的肾脏预后最差,低危组的肾脏预后最好。在组织学分类中,从“局灶性”(最佳)到“混合性”、“新月体性”和“硬化性”(最差)类别的生存情况逐渐恶化,与该系统最初的建议顺序不同。多变量 Cox 回归分析显示,RRS 与 ESRD 独立相关。使用受试者工作特征曲线下面积,RRS 与组织学分类对肾脏存活率的预测差异无统计学意义。
我们评估了 RRS 在日本 AAGN 患者中的应用价值,发现它是此类患者肾脏存活率的稳定预测因子。